Clinical Trial

Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Name: Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older — clinical trial record (NCT07421037)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The objective of this study was to evaluate the safety of quadrivalent subunit influenza vaccine (adjuvant) in people aged 65 years and older.

Trial Details

NCT Number	NCT07421037
Lead Sponsor	Ab&B Bio-tech Co., Ltd.JS Collaborators: Yither Biotech Co., Ltd
Conditions	Influenza, Influenza Vaccine
Enrollment	80 participants
Start Date	2025-11-13
Primary Completion	2026-12-13 (estimated)
Study Completion	2026-12-13 (estimated)
Updated on ClinicalTrials.gov	2026-02-19